Status:

COMPLETED

MODULA Modul 5 BEAT-HF

Lead Sponsor:

Boston Scientific Corporation

Collaborating Sponsors:

Guidant Corporation

Conditions:

Heart Failure

Eligibility:

All Genders

18+ years

Brief Summary

Detektion and Registration of Atrial Tachyarrhythmias at Patients with Heart Failure; What proportion of patients with CRT-therapy are affected at least temporarily by Atrial Arrhythmia?

Detailed Description

How many patients with CRT-therapy are affected at least temporarily by Atrial Arrhythmia in terms of rate, characteristics and severity of atrial rhythm disturbances at patients with CRT-therapy with...

Eligibility Criteria

Inclusion

  • patient under CRT-D or CRT-P therapy

Exclusion

  • patients with permanent Atrial Fibrillation

Key Trial Info

Start Date :

August 1 2003

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

May 1 2007

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT00273091

Start Date

August 1 2003

End Date

May 1 2007

Last Update

February 23 2017

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Herzzentrum / Klinik für Kardiologie / Robert-Koch-Allee 9

Bad Berka, Germany

MODULA Modul 5 BEAT-HF | DecenTrialz